circRNA basic information
circBase ID: hsa_circ_0002926
Name: hsa_circ_KDM4B
Synonym: circKDM4B
Host Gene: KDM4B
Genomic location(hg19): chr19:5047486-5082515:+
Genomic location(hg38): chr19:5047475-5082504:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007254
MONDO name: breast cancer
Disease details: breast cancer
Disease DO ID:
1612
Disease MeSH ID:
-
Disease NCIt ID:
C9335
Disease ICD11 ID:
1047754165
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

BC tissues; non-tumor tissues adjacent to carcinoma; xenograft tumors; lungs; livers

Cell lines:

MDA-MB-231; MDA-MB-468; MCF-7; T47D; HUVECs; MCF 10A

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
DN
Associated gene: AGO2, NEDD4L, PI3KCA, VEGFA
Associated microRNA: miR-675
Biological function: Suppresses breast cancer cell migration and invasion, tumor growth, metastasis, HUVEC migration and tube formation, and angiogenesis.
Molecular mechanism: circKDM4B acts as a miR-675 sponge, upregulates NEDD4L, promotes PI3KCA ubiquitination, and inhibits PI3K/AKT signaling and VEGFA secretion.
Biological pathway or process:

ceRNA regulation (other); PI3K/AKT (inhibits); ubiquitination (promotes); migration (inhibits); invasion (inhibits); metastasis (inhibits); angiogenesis (inhibits); VEGF/VEGFR (inhibits)

Detected method:
Q
S
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; RNA-seq; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Transwell Assay; Tube Formation Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); ELISA; Western Blot; ROC Analysis; Bioinformatics Analysis

Clinical significance:

circKDM4B expression could distinguish breast cancer tumor tissues from non-tumor tissues with AUC 0.9080 and may be a potential therapeutic target for breast cancer progression.

Description:

circKDM4B (hsa_circ_0002926) is down-regulated in breast cancer tissues and functions as a tumor suppressor. It sponges miR-675 to increase NEDD4L, promoting PI3KCA ubiquitination and inhibiting PI3K/AKT signaling, VEGFA secretion, angiogenesis, migration, invasion, tumor growth and metastasis. Its expression shows diagnostic potential for distinguishing tumor from non-tumor tissues and may represent a therapeutic target.

Confidence score:

0.8933

Other information
Title:

CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis.

Journal: Oncogene
Published: 2022
PubMed ID: 35145234
Study type:

combined biological and clinical study

Data availability: GSE163346; data available in the article or from the corresponding author upon reasonable request; supplementary material available at https://doi.org/10.1038/s41388-022-02232-x
Code availability: -